EBOS in $3.75 billion deal to buy Greencross; Macquarie, UBS on raise
It’s down to short strokes at ASX-listed pharma distributor EBOS’s tilt for TPG Capital’s pets and vets business Greencross.
Source: afr.com
David Mustow News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David Mustow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Mustow Today - Breaking & Trending Today
Macquarie-advised EBOS hounds Greencross; deal in the offing
Greencross’ latest accounts, for the 12 months to June 26, show revenues climbed from $1.3 billion to $1.6 billion. Net profit after tax fell from $88 million in 2021 to $83 million.
Source: afr.com
ASX sell-off: Sliding valuations alone won't ignite M&A, say CEOs
Deal activity has softened from a breakneck pace in recent months following interest rate rises and greater uncertainty about the global economic outlook.
Source: afr.com
M&A Conference: Expect more Grok-AGL style ESG hits
Buying shares in a company ahead of a bid can be an effective M&A tactic. Increasingly, it’s one ESG activists may seek to use - and regulators should demand clearer explanations of the real underlying shareholdings.
Source: afr.com